Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 24;28(4):271-273.
doi: 10.5455/msm.2016.28.271-273.

COMPARISON BETWEEN SUBLINGUAL AND VAGINAL ROUTE OF MISOPROSTOL IN MANAGEMENT OF FIRST TRIMESTER MISCARRIAGE MISSING

Zahra Dehbashi  1 , Mahmood Moosazadeh  2 , Mahdi Afshari  3
Affiliations

COMPARISON BETWEEN SUBLINGUAL AND VAGINAL ROUTE OF MISOPROSTOL IN MANAGEMENT OF FIRST TRIMESTER MISCARRIAGE MISSING

Zahra Dehbashi et al. Mater Sociomed. .

Abstract

Background: Each year, more than forty million abortions are occurred whole of the world. Misoprostol is a prostaglandin analogue with a strong uterotonic effect. The present study aimed to compare the efficacy of Misoprostol in first trimester abortion through two sublingual and vaginal routes of administration.

Methods: This randomized clinical trial was conducted on 52 consecutive women in first trimester candidate for pregnancy termination because of fetal IUFD or missed abortion in sonography reports. The patients were hospitalized and then randomly assigned to receive sublingual Misoprostol (400 µg, n 27) or vaginal Misoprostol (400 µg placed in posterior fornix, n = 25).

Findings: None of the pregnant in the sublingual group developed complete abortion at the end of follow-up time, while 36% of women inducted with vaginal misoprostol experienced complete abortion indicating a intergroup significant difference (p = 0.001). Compared with vaginal group, those women in sublingual group experienced more complications including diarrhea (22.2% versus 20.0%), nausea and vomiting (22.2% versus 0.0%), and abdominal pain (3.7% versus 0.0%).

Conclusion: The use of Misoprostol in vaginal route results in more abortion completeness as well as lower complication rate as compared to sublingual prescription of the drug.

Keywords: Abortion; Misoprostol; Pregnancy termination; Sublingual; Vaginal route.

PubMed Disclaimer

Conflict of interest statement

• Conflict of interest: The authors report no conflict of interest related to this paper.

References

    1. Sedgh G, Henshaw SK, Singh S, Bankole A, Drescher J. Legal abortion worldwide: incidence and recent trends. Int Fam Plan Perspect. 2007;33(3):106–16. - PubMed
    1. Urquhart DR, Templeton AA, Shinewi F, Chapman M, Hawkins K, McGarry J. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation: UK Multicentre Study - final results. Contraception. 1997;55:1–5. - PubMed
    1. Blanchard K, Tara Shochet T, Coyajic K, Ngoc N, Winikoff B. Misoprostol alone for early abortion: an evaluation of seven potential regimens. Contraception. 2005;72:91–7. - PubMed
    1. Costa SH. Commercial availability od misoprostol and induced abortion in Brazil. International Journal of Gynaecology and Obstetrics. 1998;63(Suppl 1):S131–9. - PubMed
    1. Kapp N, Whyte P, Tang J, Jackson E, Brahmi D. A review of evidence for safe abortion care. Contraception. 2013;88(3):350–63. - PubMed

LinkOut - more resources